A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study.
Kim
Chae-Yong
CY
Department of Neurosurgery, Seoul National University Bundang Hospital, Gyeonggi-do, Korea. chaeyong@snu.ac.kr
Kim
Seung-Ki
SK
Phi
Ji Hoon
JH
Lee
Min Mi
MM
Kim
In Ah
IA
Kim
Il Han
IH
Wang
Kyu-Chang
KC
Jung
Hye-Lim
HL
Lee
Mee Jeong
MJ
Cho
Byung-Kyu
BK
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D020295:Brain Stem Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D017024:Chemotherapy, Adjuvant; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D007723:Korea; D008297:Male; D011149:Pons / Q000187:drug effects* / Q000473:pathology / Q000528:radiation effects; D000077204:Temozolomide; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects
D013792:Thalidomide; D003606:Dacarbazine; D000077204:Temozolomide